scorecardresearch
Friday, August 29, 2025
TopicCovaxin

Topic: Covaxin

Covishield production projected to reach 120 mn doses/month, Covaxin to 58 mn doses: Mandaviya

Health minister Mansukh Mandaviya while responding to a question on the current capacity to manufacture Covid vaccines said it is projected to go forward from August to December 2021.

Covaxin effective against Delta, other variants despite reduced antibody activity: ICMR study

Delta is believed to be one of the factors that catalysed India's second Covid wave. Further mutations in Delta have led to other variants, leading to concerns about vaccine efficacy.

CDSCO expert panel recommends nod to conduct trial of mixing Covaxin, Covishield doses

The study, conducted by Christian Medical College in Vellore, aims to assess whether a person can be given two different Covid vaccine shots to complete the inoculation course.

Brazil suspends decision to import 4 million doses of Bharat Biotech’s Covaxin

Brazil's decision came after Bharat Biotech terminated its pact with the country after its deal to supply 20 million Covaxin doses attracted investigation by Brazilian authorities.

How Brazil-Bharat Biotech deal for Covaxin crumbled in less than 30 days

The Jair Bolsonaro-led Brazil government cancelled Indian drugmaker Bharat Biotech’s emergency use authorisation request for its Covaxin vaccine on 24 July.

15 crore vaccine doses expected in August delays plan of 1 crore daily shots

Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.

Over 2.28 crore Covid vaccine doses still in stock with states, UTs, says health ministry

More than 45.73 crore vaccine doses have been supplied to states/UTs so far. Of this, total consumption, including wastage, stands at 43,80,46,844 doses, as per 8 am data Tuesday.

Brazil scraps Covaxin’s emergency use request after Bharat Biotech terminates vaccine pact

The termination came after the deal with the Brazilian Government for the supply of 20 million doses of the Covaxin landed in controversy and attracted investigation by authorities.

Brazil suspends Covaxin clinical trials after Bharat Biotech cancels vaccine pact

Bharat Biotech Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its vaccine for the Brazilian market.

Assessing Covaxin data for emergency use listing, decision date yet to be confirmed: WHO

Suchitra Ella of Bharat Biotech said approval is not expected to be a long process as majority of Bharat Biotech's facilities have been audited and approved by WHO in the past.

On Camera

How economic planning stifled India’s growth and talent

The Indian planning system did not encourage individuals based on ‘what they knew’, but on ‘whom they knew’. Many left for countries that recognised their talent.

All bets off as online gaming bill shakes industry & key players suspend ‘gambling’ on their platforms

The new law, which the government has framed as a moral duty, forced major platforms like Dream11 & Zupee to shut operations, wiping out hundreds of crores in market capitalisation. 

Post-Sindoor, joint doctrine tasks Special Forces with fighting info warfare & countering propaganda

Joint Doctrine for Special Forces Operations, released Wednesday, also outlines plans for the future expansion of AFSOD and the creation of Joint Service Training Institutes.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.